Alka-Seltzer Antacid Will 'Plop, Plop Fizz, Fizz' Without Aspirin
Executive Summary
In advance of a US FDA advisory panel meeting on the safety of OTC monograph antacid/aspirin products, Bayer is removing aspirin from its pioneering Alka-Seltzer effervescent indigestion products. Bayer's Andre Schmidt talks about the safety advantages and consumer trends that helped spur the change.
You may also be interested in...
Coppertone, One-A-Day Sales Slump As Bayer’s Consumer Health Slide Continues
Bayer reported consumer health sales globally fell 1.4% to $1.64bn after a late start to the allergy season drove down Claritin sales. Aleve analgesics sales grew 3.3% to $112.5m on US line extensions while Alka Seltzer line sales were flat at $47.5m.
Alka-Seltzer Plus Labeling Error Prompts Recall From Some US Stores
Recall is second in a year for products marketed under the iconic Alka-Seltzer brand.
Alka-Seltzer Plus Labeling Error Prompts Recall From Some US Stores
Recall is second in a year for products marketed under the iconic Alka-Seltzer brand.